Clinical Trials

Movano Completes Blood Pressure Study with 110 Participants

The Company plans to execute its second glucose clinical study in the first quarter of 2022  Movano Inc., a health technology company designing devices that...

Jolly Good to study VR therapy for chronic pain in Japan

The research targets people with complex regional pain syndrome, post-stroke pain, and other pain-induced conditions. Japanese medical device maker Jolly Good and the Pain Center...

ONWARD Announces Completion of Enrollment in the Up-LIFT Pivotal Trial of ARC Therapy for Spinal Cord Injury

Enrollment was completed in less than 12 months despite COVID-related challenges, demonstrating strong interest in the therapy ONWARD Medical N.V. (Euronext: ONWD), the medical technology...

AtaCor Medical Completes Enrollment in its Initial Acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study

 AtaCor Medical, Inc. announced today that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study. Named the PASS-PULL EV-ICD Study,...

ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London

Study to Bolster Clinical Evidence of Performance of Patented TAEUS®Ultrasound Device in NAFLD Patients as Early Product Commercialization in Europe Continues ENDRA Life Sciences Inc. (ENDRA)...

Baxter touts data supporting use of machine learning for infusion pump programming

Baxter (NYSE:BAX) announced today that data shows the potential for machine learning supporting decision-making with infusion pump programming. Deerfield, Illinois-based Baxter presented the data from a...

Boston Scientific launches trial of modular, leadless pacemaker-defibrillator system

Boston Scientific has begun a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable...

Texas A&M Health, Wave Neuroscience Announce Second Phase of PTSD Clinical Trial

Efficacy and safety of innovative Magnetic EEG-guided Resonance Therapy (MeRT) will be evaluated Texas A&M University Health Science Center (Texas A&M Health) and Wave Neuroscience...

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place December 6 -...
1...454647...59Page 46 of 59

Latest articles